Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis.

Chunling WuYing SunXiaomeng CuiSifan WuLili MaHuiyong ChenYan YanZongfei JiYun LiuJiang LinPeng LvRongyi ChenPingting YangXiufang Kong

Published in: Therapeutic advances in chronic disease (2020)

LEF might provide a quicker treatment response with lower prevalence of disease relapse compared with that elicited in MTX during 12 months follow-up for TAK.

Keyphrases

risk factors
high dose
combination therapy
low dose
replacement therapy
smoking cessation